[Intracavernous infusion of drugs].
In 1982 Virag presented the initial experience of use in diagnosis and treatment of impotence. PGE1 has been showed a safe and effectiveness drug. From september 1989 to october 1991 210 patients with erectile disorders were managed by I.C.I. with PGE1 with minimal side effects.
Bellorofonte
C
C
Servizio Urologia-Pio Albergo Trivulzio, Milano.
Dell'Acqua
S
S
Ruoppolo
M
M
Zaatar
C
C
Tombolini
P
P
D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D007650:Ketanserin / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D010208:Papaverine / Q000008:administration & dosage / Q000627:therapeutic use; D010413:Penis; D010646:Phentolamine / Q000008:administration & dosage / Q000627:therapeutic use; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000627:therapeutic use; D015016:Yohimbine / Q000008:administration & dosage / Q000627:therapeutic use
D015016:Yohimbine; D014660:Vasoactive Intestinal Peptide; D007650:Ketanserin; D010208:Papaverine; D000527:Alprostadil; D010646:Phentolamine
La farmacoinfusione intracavernosa.